Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IRCT2017031133016N1Phase 2Completed
Phase 2 trial of progesterone and nifedipine in preterm birth (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoint: Prevention of preterm delivery. Started Jun 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on IRCT2017031133016N1.